Lumasiran at birth changes the trajectory of primary hyperoxaluria type 1: same disease, different outcomes in two affected siblings.
Lumasiran 於新生兒期使用改變了第一型原發性高草酸尿症(primary hyperoxaluria type 1)的病程:同一疾病,兩位受影響手足卻有不同結局
J Nephrol 2025-07-09
Identification and Cross-Platform Validation of Sparse Molecular Classifiers for Antibody-Mediated and T-Cell-Mediated Rejection After Kidney Transplantation.
腎臟移植後抗體介導與T細胞介導排斥反應之稀疏分子分類器的鑑定與跨平台驗證
Kidney Int Rep 2025-07-09
Long-Term Follow-Up of a Glucocorticoid Minimizing Regimen for the Treatment of Severe Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
嚴重抗中性球胞漿抗體相關血管炎採用類固醇最小化治療方案之長期追蹤
Kidney Int Rep 2025-07-09
Randomized, Positive-Controlled Study on the Efficacy and Safety of Oral Polysaccharide-Iron Complex Therapy in Patients on Hemodialysis.
口服 Polysaccharide-Iron Complex 治療血液透析患者之療效與安全性的隨機、陽性對照研究
Kidney Int Rep 2025-07-09
Effect of Sleep Characteristics on Rapid Estimated GFR Decline in Adults with Normal Kidney Function.
睡眠特徵對腎功能正常成人快速估算腎絲球過濾率(eGFR)下降的影響
Kidney Int Rep 2025-07-09
The Discrepancy Between Estimated GFR Cystatin C and Estimated GFR Creatinine at 3 Months After Hospitalization and Long-Term Adverse Outcomes.
住院後三個月 Estimated GFR Cystatin C 與 Estimated GFR Creatinine 之間的差異與長期不良預後
Kidney Int Rep 2025-07-09